Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement

Published:2019-05-19 Issue:10 Volume:210 Page:462-468
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Doyle Joseph¹²³,Raggatt Michelle²³,Slavin Monica⁴⁵,McLachlan Sue‐Anne⁵⁶,Strasser Simone I⁷⁸,Sasadeusz Joseph J³⁹,Howell Jessica⁶,Hajkowicz Krispin¹⁰,Nandurkar Harshal¹¹¹,Johnston Anna¹²¹³,Bak Narin¹⁴,Thompson Alexander J⁵⁶

Affiliation:

1. Monash University Melbourne VIC

2. Disease Elimination ProgramBurnet Institute Melbourne VIC

3. Alfred Health Melbourne VIC

4. Peter MacCallum Cancer Institute Melbourne VIC

5. University of Melbourne Melbourne VIC

6. St Vincent's Hospital Melbourne VIC

7. AW Morrow Gastroenterology and Liver CentreRoyal Prince Alfred Hospital Sydney NSW

8. University of Sydney Sydney NSW

9. Victorian Infectious Diseases ServiceRoyal Melbourne Hospital Melbourne VIC

10. Royal Brisbane Hospital Brisbane QLD

11. Australian Centre for Blood Diseases Melbourne VIC

12. Royal Hobart Hospital Hobart TAS

13. University of Tasmania Hobart TAS

14. Royal Adelaide Hospital Adelaide SA

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.50160

Reference39 articles.

1. Mapping progress in chronic hepatitis B: geographic variation in prevalence, diagnosis, monitoring and treatment, 2013-15

2. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005

3. Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017

4. American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

5. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Hepatitis B Infection: New Approaches towards Cure;Biomolecules;2023-08-01

2. Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies;Clinical Microbiology and Infection;2022-10

3. Australian consensus recommendations for the management of hepatitis B;Medical Journal of Australia;2022-03-06

4. Very late-onset hepatitis B reactivation following chemoimmunotherapy;Leukemia & Lymphoma;2021-12-02

5. Hepatitis B in haematology patients receiving intravenous immunoglobulin: highlighting a core issue;Internal Medicine Journal;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3